Founded 1984. Research commenced 1984, production started 1988. Annual revenue ~USD 169M with 589 employees. Factory: Behind El Obour Market, 300 Street, Block 13007, 1st Industrial Zone, Obour City. Produces and markets a wide range of human and veterinary pharmaceuticals for the Egyptian market and regional export.
One of Egypt's leading private pharmaceutical manufacturers. Factory: 1st Industrial Zone, Block 13015, El Obour City, Qalyubia. Annual revenue ~USD 112M. 955 employees. Produces a wide range of human pharmaceuticals for domestic and export markets across the Middle East and Africa.
Egyptian pharmaceutical manufacturer based in Amriya, Alexandria. Factory: KM 25, Cairo-Alexandria Desert Road, Al Agamy Al Qebleyah, Amriya 1. Produces pharmaceutical formulations for the domestic market and regional export.
Egyptian joint stock company engaged in production, marketing, sales, and importation of pharmaceutical products. Building new factory with initial investment exceeding EGP 1 billion. Focus on diabetes, common disease tablets, and capsules. Factory: Plot 226, Second Sector, City Center, 5th Settlement, New Cairo. Annual revenue ~USD estimated mid-tier.
Founded 2006. Produces and markets pharmaceuticals from a 12,600 sqm manufacturing plant in 6th of October City. Strictly adheres to cGMP. 787 employees. Annual revenue ~USD 127M. Distributes pharmaceutical products across Egypt through various business models and continues to invest heavily in production equipment.
Egyptian pharmaceutical manufacturer listed on the official Pharmaceuticals Index for Egypt. Produces pharmaceutical formulations for the Egyptian and regional markets. GMP-compliant manufacturing operations.
Established Egyptian pharmaceutical manufacturer listed among key players in Egypt's pharmaceutical sector by multiple authoritative industry reports. Deltapharma.com.eg. Produces a range of pharmaceutical formulations for the Egyptian market.
Egyptian subsidiary of Otsuka Pharmaceutical, a global Japanese pharmaceutical company. Produces Otsuka-branded and generic pharmaceutical products for the Egyptian market. Part of the global Otsuka group with presence across the Middle East and Africa.
Established 1980. Largest Egyptian pharmaceutical manufacturer by volume and largest in the Middle East by volume. First Egyptian company to implement cGMP regulations throughout all operational departments. Largest sterile manufacturing areas in the MENA region. Pioneer in spansule capsules, soft gelatin capsules, lyophilized products, gels, sprayers, and effervescent tablets. Factory: 10th of Ramadan City, 1st Industrial Zone B1.
Founded 1997, built on the heritage of Les Laboratoires Delta — Egypt's second-oldest pharmaceutical company. One of the fastest-growing pharmaceutical manufacturers in the MENA region with 30%+ CAGR over five years. Portfolio of 126+ products across neurology, psychiatry, cardiovascular, orthopedics, GIT, pediatrics, urology, and dermatology. Manufacturing facility approved by EMA, SFDA, and GCC authorities. Annual capacity of 22 million units of immunotherapy, hematology, and oncology medication. Presence in Egypt, KSA, UAE, Bahrain, Qatar, Oman, Kuwait, Iraq, Lebanon, Yemen, Kenya, Libya, and Ethiopia. HQ: Armanious Group Tower, 9 El Sharekat St., Opera, Abdeen, Cairo.
Egyptian pharmaceutical manufacturer. Factory: 1st Industrial Zone, 4G, Badr City, Cairo. Produces pharmaceutical formulations for domestic and export markets. GMP-certified manufacturing. Hotline: 19790.
One of Egypt's top certified contract manufacturers for both multinational and domestic companies. ISO 9001 and ISO 17025 quality laboratory certified. Four branches across Egypt. Products distributed worldwide. 1,600+ employees. Annual revenue ~USD 23M. Based in 6th of October City. Produces high-quality generic medicines at affordable prices.
Egyptian subsidiary of Hikma Pharmaceuticals, a global pharmaceutical company listed on the London Stock Exchange. Produces injectable and non-injectable pharmaceuticals in Egypt. Part of a $2.9B global revenue group. Manufactures generics and branded medicines for Egyptian and international markets.
Major Egyptian pharmaceutical distribution and manufacturing company. Listed by Nexdigm as a key player in Egypt's pharmaceutical manufacturing market. One of Egypt's largest pharmaceutical distributors with manufacturing operations. Supplies medicines to pharmacies and hospitals across Egypt.
Egyptian pharmaceutical manufacturer listed by Nexdigm among major players in Egypt's pharmaceutical market. Produces innovative and generic pharmaceutical products for the Egyptian healthcare sector.
Egyptian pharmaceutical company listed by Nexdigm as a major player in Egypt's pharmaceutical manufacturing market. Produces and markets pharmaceutical products for the Egyptian market and regional export.
Founded 1998. Entered Egypt's top 10 highest-grossing pharmaceutical companies in 2015. Factory: El Obour City, West Extension, Block 20005, Cairo. Phone: +20244892641. First bilayer tablet manufacturing line in Egypt. Developing separate hormone manufacturing facility — one of only a few in the Middle East. Strong R&D and Quality Control Lab with latest analytical instruments. Fully GMP-compliant.
One of Egypt's established pharmaceutical manufacturers. 1,030 employees. Annual revenue ~USD 129M. Produces a broad portfolio of pharmaceutical formulations for the Egyptian market and regional export. GMP-compliant manufacturing operations.
Address: 36 Dr Mohamed Hassan El Gamal Street, 6th District, Nasr City, Cairo 11768. Website: mupeg.com. Egyptian pharmaceutical manufacturer producing a broad portfolio of pharmaceutical formulations for domestic and regional export markets. GMP-compliant manufacturing operations.
Founded 1958. Leading biopharmaceutical company in Egypt, the Middle East, and Africa — the largest biosimilars manufacturer in Africa. Over 20 years of experience in cellular and bioprocess engineering. Portfolio of 100+ life-saving products from small molecules to complex genetically engineered proteins. Strategic partnership with IAVI and ProBioGen for vaccine and biologics manufacturing. DEG Impulse-funded for women's health and family planning products. Acquired global rights for Praxilene® from Merck in January 2026. HQ: Nasr City, Cairo.
Egyptian pharmaceutical company founded 1996. Based in 6th of October City. 997 employees. Annual revenue ~USD 100M. One of Egypt's top pharmaceutical companies producing and distributing a wide range of medicines for the domestic and regional markets.
Located at Plot 190, Street 25, 1st Industrial Zone 38, 6th of October City. Phone: +20238201832. Aspires to be a leading modern pharmaceutical company adhering to advanced marketing, regulatory, and manufacturing standards. Develops and manufactures high-quality, effective, and affordable generics using innovative drug delivery techniques.
Egyptian pharmaceutical manufacturer based in 6th of October City. 500 employees. Annual revenue ~USD 143M. Produces and markets pharmaceutical products for domestic and export markets. GMP-certified production facilities.
Egyptian pharmaceutical manufacturer with 572 employees and annual revenue ~USD 57M. Produces pharmaceutical formulations for the domestic Egyptian market and regional export.